Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alloway

Showing results (251-260 of 360) with videos related to

Pageof 36
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2013
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipientsN S Ejaz, A R Shields, R R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Polyomavirus nephropathy in kidney transplantationJennifer Trofe, Jennifer Gordon, Prabir Roy-Chaudhury, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Nature Communications|May 10, 2016
Radiocarbon constraints on the extent and evolution of the South Pacific glacial carbon poolT A Ronge, R Tiedemann, F Lamy, et al.
Transplantation Proceedings|September 13, 2015
Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous ImmunoglobulinJ Y Revollo, M C Cuffy, B G Abu Jawdeh, et al.
Journal of Clinical Pharmacology|June 24, 2003
The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patientsCharles R Yates, Wenhui Zhang, Pengfei Song, et al.
Transplantation|February 1, 2000
Simultaneous kidney-pancreas transplantation without antilymphocyte inductionK S Reddy, R J Stratta, H Shokouh-Amiri, et al.
Paediatrics & Child Health|June 2, 2012
One-on-one lifestyle coaching for managing adolescent obesity: Findings from a pilot, randomized controlled trial in a real-world, clinical settingGeoff Dc Ball, Kelly A Mackenzie-Rife, Mandi S Newton, et al.
Transplantation Proceedings|April 26, 2005
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experienceJ F Buell, T G Gross, M J Hanaway, et al.
Pageof 36

Showing results (251-260 of 360) with videos related to

Sort By:
Pageof 36
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2013
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipientsN S Ejaz, A R Shields, R R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Polyomavirus nephropathy in kidney transplantationJennifer Trofe, Jennifer Gordon, Prabir Roy-Chaudhury, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Transplantation|July 28, 2012
Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipientsNicole Schmidt, Rita R Alloway, R Carlin Walsh, et al.
Nature Communications|May 10, 2016
Radiocarbon constraints on the extent and evolution of the South Pacific glacial carbon poolT A Ronge, R Tiedemann, F Lamy, et al.
Transplantation Proceedings|September 13, 2015
Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous ImmunoglobulinJ Y Revollo, M C Cuffy, B G Abu Jawdeh, et al.
Journal of Clinical Pharmacology|June 24, 2003
The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patientsCharles R Yates, Wenhui Zhang, Pengfei Song, et al.
Transplantation|February 1, 2000
Simultaneous kidney-pancreas transplantation without antilymphocyte inductionK S Reddy, R J Stratta, H Shokouh-Amiri, et al.
Paediatrics & Child Health|June 2, 2012
One-on-one lifestyle coaching for managing adolescent obesity: Findings from a pilot, randomized controlled trial in a real-world, clinical settingGeoff Dc Ball, Kelly A Mackenzie-Rife, Mandi S Newton, et al.
Transplantation Proceedings|April 26, 2005
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experienceJ F Buell, T G Gross, M J Hanaway, et al.
Pageof 36